Cargando…
Hearing Benefits of Clinical Management for Meniere’s Disease
Meniere’s disease is a progressive hearing–disabling condition. Patients can benefit from strict clinical management, including lifestyle and dietary counseling, and medical treatment. A prospective cohort study was carried out with 154 patients with definite Meniere’s disease, with an average age o...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181791/ https://www.ncbi.nlm.nih.gov/pubmed/35683514 http://dx.doi.org/10.3390/jcm11113131 |
_version_ | 1784723870919426048 |
---|---|
author | Zhang, Yi Wei, Chenyi Sun, Zhengtao Wu, Yue Chen, Zhengli Liu, Bo |
author_facet | Zhang, Yi Wei, Chenyi Sun, Zhengtao Wu, Yue Chen, Zhengli Liu, Bo |
author_sort | Zhang, Yi |
collection | PubMed |
description | Meniere’s disease is a progressive hearing–disabling condition. Patients can benefit from strict clinical management, including lifestyle and dietary counseling, and medical treatment. A prospective cohort study was carried out with 154 patients with definite Meniere’s disease, with an average age of 43.53 ± 11.40, and a male to female ratio of 0.97:1. The pure-tone thresholds of all 165 affected ears, over a one-year clinical management period, were analyzed. After one year, 87.27% of patients had improved or preserved their hearing at a low frequency, and 71.51% at a high frequency. The hearing threshold at frequencies from 250 Hz to 2000 Hz had improved significantly (p < 0.001, p < 0.001, p < 0.001, p < 0.01), and deteriorated slightly at 8000 Hz (p < 0.05). Of all the patients, 40.00% had a hearing average threshold that reached ≤25 dB HL after the clinical management period, among whom 27.27% were patients in stage 3. The restoration time was 2.5 (1.0, 4.125) months, with a range of 0.5–11.0 months, and the restoration time was longer for stage 3 than for stages 1 and 2 (u = −2.542, p < 0.05). The rising curves improved the most (p < 0.05), with most becoming peaks, whereas most peaks and flats remained the same. Patients who were initially in the earlier stages (95% CI 1.710~4.717, OR 2.840, p < 0.001), have an increased odds ratio of hearing by an average of ≤25 dB HL. Age (95% CI 1.003~1.074, OR 1.038, p = 0.031), peak curve (95% CI 1.038~5.945, OR = 2.484, p = 0.041), and flat curve (95% CI 1.056~19.590, OR = 4.549, p = 0.042), compared with the rising curve, increase the odds ratio of hearing on average by >25 dB HL. Most patients can have their hearing preserved or improved through strict clinical management, and sufficient follow-up is also essential. Stage 3 patients also have the potential for hearing improvement, although the restoration time is longer than in the early stages. The initial hearing stage, age, and audiogram pattern are related to the hearing benefits. |
format | Online Article Text |
id | pubmed-9181791 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-91817912022-06-10 Hearing Benefits of Clinical Management for Meniere’s Disease Zhang, Yi Wei, Chenyi Sun, Zhengtao Wu, Yue Chen, Zhengli Liu, Bo J Clin Med Article Meniere’s disease is a progressive hearing–disabling condition. Patients can benefit from strict clinical management, including lifestyle and dietary counseling, and medical treatment. A prospective cohort study was carried out with 154 patients with definite Meniere’s disease, with an average age of 43.53 ± 11.40, and a male to female ratio of 0.97:1. The pure-tone thresholds of all 165 affected ears, over a one-year clinical management period, were analyzed. After one year, 87.27% of patients had improved or preserved their hearing at a low frequency, and 71.51% at a high frequency. The hearing threshold at frequencies from 250 Hz to 2000 Hz had improved significantly (p < 0.001, p < 0.001, p < 0.001, p < 0.01), and deteriorated slightly at 8000 Hz (p < 0.05). Of all the patients, 40.00% had a hearing average threshold that reached ≤25 dB HL after the clinical management period, among whom 27.27% were patients in stage 3. The restoration time was 2.5 (1.0, 4.125) months, with a range of 0.5–11.0 months, and the restoration time was longer for stage 3 than for stages 1 and 2 (u = −2.542, p < 0.05). The rising curves improved the most (p < 0.05), with most becoming peaks, whereas most peaks and flats remained the same. Patients who were initially in the earlier stages (95% CI 1.710~4.717, OR 2.840, p < 0.001), have an increased odds ratio of hearing by an average of ≤25 dB HL. Age (95% CI 1.003~1.074, OR 1.038, p = 0.031), peak curve (95% CI 1.038~5.945, OR = 2.484, p = 0.041), and flat curve (95% CI 1.056~19.590, OR = 4.549, p = 0.042), compared with the rising curve, increase the odds ratio of hearing on average by >25 dB HL. Most patients can have their hearing preserved or improved through strict clinical management, and sufficient follow-up is also essential. Stage 3 patients also have the potential for hearing improvement, although the restoration time is longer than in the early stages. The initial hearing stage, age, and audiogram pattern are related to the hearing benefits. MDPI 2022-05-31 /pmc/articles/PMC9181791/ /pubmed/35683514 http://dx.doi.org/10.3390/jcm11113131 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Zhang, Yi Wei, Chenyi Sun, Zhengtao Wu, Yue Chen, Zhengli Liu, Bo Hearing Benefits of Clinical Management for Meniere’s Disease |
title | Hearing Benefits of Clinical Management for Meniere’s Disease |
title_full | Hearing Benefits of Clinical Management for Meniere’s Disease |
title_fullStr | Hearing Benefits of Clinical Management for Meniere’s Disease |
title_full_unstemmed | Hearing Benefits of Clinical Management for Meniere’s Disease |
title_short | Hearing Benefits of Clinical Management for Meniere’s Disease |
title_sort | hearing benefits of clinical management for meniere’s disease |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181791/ https://www.ncbi.nlm.nih.gov/pubmed/35683514 http://dx.doi.org/10.3390/jcm11113131 |
work_keys_str_mv | AT zhangyi hearingbenefitsofclinicalmanagementformenieresdisease AT weichenyi hearingbenefitsofclinicalmanagementformenieresdisease AT sunzhengtao hearingbenefitsofclinicalmanagementformenieresdisease AT wuyue hearingbenefitsofclinicalmanagementformenieresdisease AT chenzhengli hearingbenefitsofclinicalmanagementformenieresdisease AT liubo hearingbenefitsofclinicalmanagementformenieresdisease |